i-Divine

i-Divine is an AI-powered drug discovery company that operates as a specialized division of Aragen Life Sciences. The company leverages a proprietary platform built on advanced machine learning and deep learning architectures to accelerate the identification and optimization of novel therapeutic candidates. Its core technology, which stands for "Intelligent Drug Discovery and In-silico Validation for Innovative New Entities," provides integrated solutions for virtual screening, scaffold hopping, and predictive toxicology. By combining computational intelligence with Aragen's extensive laboratory and manufacturing infrastructure, i-Divine offers an end-to-end discovery service for global pharmaceutical and biotechnology partners. The platform is designed to significantly reduce the time and cost associated with early-stage drug development across various therapeutic areas, including oncology and immunology.